Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Analysis of Immunogenicity of the Nonavalent Human Papillomavirus Vaccination (GARDASIL 9) in Patients Post Solid Organ Transplant

NCT05557370 is registered in ClinicalTrials.gov with Medical College of Wisconsin as lead sponsor.

NCT NCT05557370
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05557370 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Analysis of Immunogenicity of the Nonavalent Human Papillomavirus Vaccination (GARDASIL 9) in Patients Post Solid Organ Transplant
Lead sponsor
Medical College of Wisconsin
Phase
Phase 4
Overall status
Active, not recruiting
Start date
June 1, 2023
Completion date
December 31, 2035
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney diseases, kidney transplant